A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections — including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic. The findings were published in the journal Nature.

Twin 9-year-old girls at Duke Health became the first in the United States to participate in a Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 among healthy children below the age of 12.

More than 5.3 million individuals — children and adults — permanently live with a brain injury-related disability, according to the Brain Injury Association of America. Two researchers from the Duke University School of Nursing, Tolu O. Oyesanya, PhD, RN, and  Karin Reuter-Rice, PhD, CPNP-AC, FCCM, FAAN, have devoted an aspect of their research toward better understanding the ramifications that brain injuries inflict on patients and their loved...